Home > Investors
Investor Relations Home
E-mail Page Print Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet 
About Us
Download Documentation 2016 Guidance Worksheet
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation Update on ABP-700
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation ABP-700 & MDCO-216 Conference Call Presentation
Corporate Profile
The Medicines Company provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients.
Stock Quote
MDCO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.2 (0.80%)
Data as of 01/19/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News
01/08/18The Medicines Company Announces Closing of Divestiture of Infectious Disease Business Unit to Melinta Therapeutics
PARSIPPANY, N.J.--(BUSINESS WIRE)--Jan. 8, 2018-- The Medicines Company (NASDAQ:MDCO) today announced the closing of the sale of its infectious disease business unit to Melinta Therapeutics, Inc. (NASDAQ: MLNT) for consideration consisting of $215 million of guaranteed cash, approximately 3.3 million shares of Melinta common stock, tiered royalty payments of 5% to 25% on worldwide net sales of Vabomere™, Orbactiv® and Minocin® IV, and the assumpti... 
Printer Friendly Version
01/03/18The Medicines Company to Present at the 36th Annual J. P. Morgan Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--Jan. 3, 2018-- The Medicines Company (NASDAQ:MDCO) today announced that its Chief Executive Officer, Clive Meanwell, M.D., Ph.D., will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018, at 8:30 a.m., Pacific Time, at The Westin St. Francis in San Francisco, CA. A Q&A breakout session will immediately follow the presentation at 9:00 a.m., Pacific Time. A live audio... 
Printer Friendly Version
12/13/17The Medicines Company to Host Investor Day on January 23, 2018
PARSIPPANY, N.J.--(BUSINESS WIRE)--Dec. 13, 2017-- The Medicines Company (NASDAQ:MDCO) today announced that it will host an Investor Day on Tuesday, January 23, 2018, from 10:00 a.m. to 12:30 p.m., Eastern Time, in New York City. The event will be led by Fred Eshelman, Pharm.D., Executive Chairman of The Medicines Company, and Clive Meanwell, M.D., Ph.D., Chief Executive Officer of the Company, who will be joined by members of the Company’s ... 
Printer Friendly Version
11/29/17The Medicines Company Announces Definitive Agreement to Sell its Infectious Disease Business Unit to Melinta Therapeutics
—Transaction will significantly strengthen the Company’s financial position; expected to provide sufficient cash and liquidity to advance inclisiran through anticipated completion of pivotal trials and data readout in second half of 2019— —Transaction structure will provide potential to create additional value through robust royalty structure on future sales of antibiotic portfolio and ownership of Melinta common stock— PARSIPPANY, N.J... 
Printer Friendly Version
Upcoming Events
01/23/18 10:00 a.m. ET
The Medicines Company Investor Day
LocationNew York, NY

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.